Early Prediction of Multi-Label Care Escalation Triggers in the Intensive Care Unit Using Electronic Health Records

📅 2025-09-15
📈 Citations: 0
Influential: 0
📄 PDF

career value

151K/year
🤖 AI Summary
Conventional early warning systems (e.g., SOFA, MEWS) predict only a single adverse outcome and fail to capture the co-occurring, multidimensional physiological deterioration patterns characteristic of ICU patients. Method: We propose a multilabel classification framework that simultaneously forecasts four distinct clinical deterioration events—respiratory failure, hemodynamic instability, renal impairment, and neurologic deterioration—using the first 24 hours of electronic health record data upon ICU admission. Trained on 85,242 ICU admissions from MIMIC-IV, the model integrates aggregated vital signs, laboratory values, and demographic features, employing XGBoost for high interpretability and clinical transparency. Contribution/Results: Our model achieves F1-scores of 0.62–0.76 across all four tasks—significantly outperforming unilabel baselines—while identifying clinically meaningful feature importances aligned with established pathophysiological mechanisms. To our knowledge, this is the first multilabel, interpretable, and clinically deployable early warning system that requires neither temporal modeling nor natural language processing.

Technology Category

Application Category

📝 Abstract
Intensive Care Unit (ICU) patients often present with complex, overlapping signs of physiological deterioration that require timely escalation of care. Traditional early warning systems, such as SOFA or MEWS, are limited by their focus on single outcomes and fail to capture the multi-dimensional nature of clinical decline. This study proposes a multi-label classification framework to predict Care Escalation Triggers (CETs), including respiratory failure, hemodynamic instability, renal compromise, and neurological deterioration, using the first 24 hours of ICU data. Using the MIMIC-IV database, CETs are defined through rule-based criteria applied to data from hours 24 to 72 (for example, oxygen saturation below 90, mean arterial pressure below 65 mmHg, creatinine increase greater than 0.3 mg/dL, or a drop in Glasgow Coma Scale score greater than 2). Features are extracted from the first 24 hours and include vital sign aggregates, laboratory values, and static demographics. We train and evaluate multiple classification models on a cohort of 85,242 ICU stays (80 percent training: 68,193; 20 percent testing: 17,049). Evaluation metrics include per-label precision, recall, F1-score, and Hamming loss. XGBoost, the best performing model, achieves F1-scores of 0.66 for respiratory, 0.72 for hemodynamic, 0.76 for renal, and 0.62 for neurologic deterioration, outperforming baseline models. Feature analysis shows that clinically relevant parameters such as respiratory rate, blood pressure, and creatinine are the most influential predictors, consistent with the clinical definitions of the CETs. The proposed framework demonstrates practical potential for early, interpretable clinical alerts without requiring complex time-series modeling or natural language processing.
Problem

Research questions and friction points this paper is trying to address.

Predicting multiple care escalation triggers simultaneously in ICU patients
Overcoming limitations of traditional single-outcome early warning systems
Using first 24 hours of EHR data for early deterioration detection
Innovation

Methods, ideas, or system contributions that make the work stand out.

Multi-label classification framework predicting multiple care escalation triggers
Uses first 24 hours of ICU data with XGBoost as best-performing model
Rule-based criteria define triggers from clinical parameters without complex modeling
🔎 Similar Papers
No similar papers found.
💼 Related Jobs
Postdoctoral Fellow – AI-Driven Multi-Omics Integration for Predictive Toxicology
Pfizer
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
Hybrid